Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 2,358 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: SARS-COV-2 Infection Clear all

Conditions: COVID-19, ARDS
Interventions: ExoFlo, Intravenous normal saline; Biological · Other
Lead sponsor: Direct Biologics, LLC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 6
States / cities: Sheffield, Alabama • Anaheim, California • Sayre, Pennsylvania + 3 more

Conditions: Long Covid
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Covid19, Fatigue
Interventions: Aromatherapy, Placebo; Other
Lead sponsor: Nutraceuticals Research Institute; Other
Eligibility: 19 Years to 49 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Franklin, Tennessee

Conditions: Covid19, Outcome, Fatal, Respiratory Failure, Acute Kidney Injury, Inflammation
Interventions: SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase; Diagnostic Test
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 4,463 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Covid19
Interventions: Exercise Training; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years to 75 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Hypertension
Interventions: Lifestyle Modification Webinars Focused on Hypertension Control; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: COVID
Interventions: mavrilimumab, Placebo; Drug · Other
Lead sponsor: Kiniksa Pharmaceuticals International, plc; Industry
Eligibility: 18 Years and older
Enrollment: 814 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 9
States / cities: Los Angeles, California • San Diego, California • Chicago, Illinois + 6 more

Conditions: COVID-19
Interventions: ALG-097558; Drug
Lead sponsor: Aligos Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 2
States / cities: Miami, Florida • Orlando, Florida

Conditions: COVID, SARS-CoV2 Infection, Covid19
Interventions: Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG), Placebo; Biological · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 741 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 16
States / cities: Tucson, Arizona • Mather, California • Palo Alto, California + 13 more

Conditions: Motivational Interviewing
Interventions: COVID-19 education; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: COVID-19
Interventions: MLS Laser, Regular Inpatient Medical Care; Device · Other
Lead sponsor: Lowell General Hospital; Other
Eligibility: 18 Years to 90 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Lowell, Massachusetts

Conditions: Heart Failure, Coronary Artery Disease, Cancer, Chronic Kidney Diseases, COPD, Obesity, Sickle Cell Disease, Diabetes Mellitus, Type 2
Interventions: Community outreach method; Other
Lead sponsor: Jesse Nodora; Other
Eligibility: 21 Years and older
Enrollment: 9,120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Post Covid-19 Respiratory, Dyspnea, SARS-CoV 2
Interventions: Respiratory Music Therapy Protocol; Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: New York, New York

Conditions: Traumatic Brain Injury, Fatigue, Cognitive Impairment, COVID-19
Interventions: Somatropin; Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 70 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Healthy Aging
Interventions: Physical and Cognitive Activity; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 50 Years to 85 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: COVID-19
Interventions: Hydroxychloroquine, Azithromycin; Drug
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: COVID-19
Interventions: CAP-1002 Allogeneic Cardiosphere-Derived Cells; Biological
Lead sponsor: Capricor Inc.; Industry
Eligibility: 18 Years and older
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Depression, Anxiety, Bipolar Disorder
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years and older
Enrollment: 193 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Emotional Distress, Burnout, Professional, Stress, Job, Anxiety, Depressive Symptoms
Interventions: LIFT Mindfulness; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Long COVID, Long Coronavirus Disease 2019 (Covid19), Long Covid-19
Interventions: IVIG (intravenous immunoglobulin), IVIG Placebo, Coordinated Care, Usual Care; Drug · Behavioral
Lead sponsor: Kanecia Obie Zimmerman; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: COVID-19
Interventions: NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg); Biological
Lead sponsor: Novavax; Industry
Eligibility: 11 Years to 18 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 20
States / cities: Davie, Florida • Jacksonville, Florida • Miami, Florida + 17 more

Conditions: COVID-19
Interventions: Exercise Prescription; Other
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Frisco, Texas

Conditions: Coronavirus Infection, COVID, Covid-19, SARS-CoV-2
Interventions: Point-of-Care Ultrasonography (POCUS); Diagnostic Test
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Saint Paul, Minnesota

Conditions: Health Disparities, Food Security
Interventions: Work requirement exemption months; Other
Lead sponsor: Harvard Medical School (HMS and HSDM); Other
Eligibility: 18 Years to 49 Years
Enrollment: 12,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Glen Allen, Virginia

Search by objective public record fields.

Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS

Validation of Biomarkers for Long COVID in the LIINC Viral Immunopathogenesis and Persistence Repeat Donor Cohort (VIPER)

Essential Oils and Post COVID-19 Fatigue

International Study of Inflammation in COVID-19

The Burden of COVID-19 Survivorship

Utilizing Telemedicine for Hypertension Treatment Lifestyle Modification in Central Harlem

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Outpatient Treatment With Anti-Coronavirus Immunoglobulin

LinkUP: COVID-19 Intervention for Underserved Populations

Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease

COVID-19 Testing in Underserved and Vulnerable Populations

The Effects of a Music Therapy Respiratory Protocol on Post-Covid-19 Respiratory Symptoms

Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

Virtual Reality Study - COVID-19 Protocol

Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients

CAP-1002 in Severe COVID-19 Disease

Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen

A Self-directed Mobile Mindfulness Intervention to Address Distress and Burnout in Frontline Healthcare Workers

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)

Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines

Exercise in Adults with Post-Acute Sequelae of SARS-CoV-2 (COVID-19) Infection Study

Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)

The Effect of Work Requirements in SNAP in Virginia